Innova Captab Limited (NSE:INNOVACAP)

Market Cap	50.11B -4.1%
Revenue (ttm)	16.37B +31.7%
Net Income	1.41B +9.9%
EPS	24.63 +9.9%
Shares Out	57.22M
PE Ratio	35.56
Forward PE	25.83
Dividend	4.00 (0.46%)
Ex-Dividend Date	Jan 30, 2026

Volume	60,012
Average Volume	130,151
Open	875.75
Previous Close	875.75
Day's Range	852.00 - 888.50
52-Week Range	622.00 - 1,020.70
Beta	-0.11
RSI	75.34
Earnings Date	May 7, 2026

About Innova Captab

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinoly...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 1,600
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INNOVACAP

Financial Performance

In fiscal year 2026, Innova Captab's revenue was 16.37 billion, an increase of 31.66% compared to the previous year's 12.44 billion. Earnings were 1.41 billion, an increase of 9.87%.